Avance Clinical has positioned itself as a global leader in early phase clinical trials by developing innovative strategies and approaches to initial phase development. It helps global biotech companies set up clinic and achieve proof of concept faster with a data package that stands up to the scrutiny of global regulators. The company is well reputed for proven support of the biotech industry by providing scientific and regulatory expertise to help develop the best strategy to achieve clinical trial outcomes in the most time- efficient manner. Read the full report here.
AUSTRALIA & ASIA-PACIFIC CRO MARKET REPORT: Frost & Sullivan
No Comments
News
Recent News
- Introducing William Faria, the New Vice President of Biometrics at Avance Clinical
- Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study
- Avance Clinical CEO Talks with SCRIP Intelligence about a New CRO Report and US Biotech Sector “Green Shoots”
- Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks
- Frost & Sullivan Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner